SCHEMBL26247191

SCHEMBL26247191

CC1(F)CCC(NC2CCCCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
HSD17B10 Q99714 1/20 0.55
ADH1B P00325 2/20 0.34
ADH1C P00326 2/20 0.34
ADH1A P07327 2/20 0.34
ADH4 P08319 1/20 0.34
THRB P10828 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
CCR2 P41597 2/20 0.32
SIGMAR1 Q99720 2/20 0.31
ADH7 P40394 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL999618 0.81 ALDH1A1 (0.60) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL26257045 0.81 ALDH1A1 (0.60) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL999708 0.81 ALDH1A1 (0.60) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL26248123 0.79 CCR2 (0.38) ALDH1A1HSD17B10CCR2
SCHEMBL26254541 0.78 EPHX2 (0.35)
SCHEMBL28599708 0.77 ALDH1A1 (0.55) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL26253719 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10ADH1BADH1CADH1A
Ethane SCHEMBL9776531 0.74 ALDH1A1 (0.86) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL24771540 0.74 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL24771539 0.74 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373950-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. 2023-11-23 US disclosed
WO-2023178181-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2023-09-21 WO disclosed
EP-4245756-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF Gilead Sciences, Inc. (US) 2023-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373950-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF IKZF2, IKZF1, IKZF3 ALDH1A1 3576/4885HSD17B10 2546/4885ADH1B 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.